Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The Norwegian multicenter study.

G Husby

    The American Journal of Medicine
    |November 28, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Piroxicam and naproxen demonstrate similar effectiveness for osteoarthritis treatment. Serious gastrointestinal side effects were rare for both nonsteroidal anti-inflammatory drugs in this large trial.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Neuropsychological functions in systemic lupus erythematosus: a comparison with chronic whiplash patients.

    European journal of neurology·2013
    Same author

    Evaluation of the VIDAS Listeria (LIS) immunoassay for the detection of Listeria in foods using demi-Fraser and Fraser enrichment broths, as modification of AOAC Official Method 999.06 (AOAC Official Method 2004.06).

    Journal of AOAC International·2005
    Same author

    Filter function and immune complex trapping in splenic ellipsoids.

    Journal of comparative pathology·2005
    Same author

    Kinetics of glycosaminoglycan deposition in splenic AA amyloidosis induced in mink.

    Scandinavian journal of immunology·2004
    Same author

    Artefacts formed by addition of urea to N-linked glycans released with peptide-N-glycosidase F for analysis by mass spectrometry.

    Rapid communications in mass spectrometry : RCM·2004
    Same author

    Crystal-induced arthritis mimicking rheumatoid arthritis in a patient with monoclonal gammopathy.

    Arthritis and rheumatism·2002
    Same journal

    GLP-1 Receptor Agonists and Age-related Macular Degeneration Risk in Diabetes or Non-diabetic Obesity: A Retrospective Cohort Study.

    The American journal of medicine·2026
    Same journal

    Marijuana Use and Acute Myocardial Infarction: Mechanistic Insights, Clinical Implications, and Emerging Challenges.

    The American journal of medicine·2026
    Same journal

    Cave Canem - Beware of the Dog.

    The American journal of medicine·2026
    Same journal

    Risk Factors for 30-day Hospital Readmission After Hospital-at-Home Treatment of Acute Pyelonephritis.

    The American journal of medicine·2026
    Same journal

    Mesenteric Panniculitis.

    The American journal of medicine·2026
    Same journal

    Hypercalcemia and hyperferritinemia in a patient with Graves' disease disease.

    The American journal of medicine·2026
    See all related articles

    Area of Science:

    • Rheumatology
    • Pharmacology

    Background:

    • Osteoarthritis (OA) is a prevalent degenerative joint disease.
    • Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used for OA pain management.
    • Piroxicam and naproxen are widely prescribed NSAIDs.

    Purpose of the Study:

    • To compare the efficacy and safety of piroxicam versus naproxen in treating osteoarthritis.
    • To assess the incidence of serious gastrointestinal side effects in patients receiving piroxicam or naproxen.

    Main Methods:

    • A multicenter, double-blind trial involving over 2,000 patients.
    • A 12-week treatment duration comparing piroxicam and naproxen.
    • Monitoring for treatment efficacy and serious gastrointestinal adverse events.

    Related Experiment Videos

    Main Results:

    • Both piroxicam and naproxen exhibited comparable efficacy in managing osteoarthritis symptoms.
    • Serious gastrointestinal side effects were infrequent, occurring in less than 1% of patients for both treatment groups.
    • Findings align with established data on NSAID safety profiles.

    Conclusions:

    • Piroxicam is as effective as naproxen for osteoarthritis treatment.
    • Piroxicam does not present a higher risk of serious gastrointestinal side effects compared to naproxen.
    • The study supports the use of piroxicam as a viable treatment option for osteoarthritis.